Showing results (851-860 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|August 5, 2021
Health Insurance Coverage and Its Associated Factors Among Reproductive-Age Women in East Africa: A Multilevel Mixed-Effects Generalized Linear ModelAdisu Birhanu Weldesenbet, Sewnet Adem Kebede, Behailu Hawulte Ayele, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 12, 2021
Barriers and Facilitators of Community-Based Health Insurance Membership in Rural Amhara Region, Northwest Ethiopia: A Qualitative StudyGetu Debalkie Demissie, Asmamaw Atnafu
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2015
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspectiveGeorge Dranitsaris, Bo Yu, Jennifer King, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 18, 2015
Prevalence and cost of imaging in inpatient falls: the rising cost of fallingJessica Fields, Tahani Alturkistani, Neal Kumar, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 18, 2015
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug ReviewAngela Rocchi, Isabelle Chabot, Judith Glennie
Clinicoeconomics and Outcomes Research : CEOR|July 8, 2015
Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failureJacqueline B Palmer, Howard S Friedman, Katherine Waltman Johnson, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 6, 2015
Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in JapanJörg Mahlich, Masamichi Nishi, Yoshimichi Saito
Clinicoeconomics and Outcomes Research : CEOR|April 28, 2021
Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure DrugsDarshan Mehta, Matthew Davis, Andrew J Epstein, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 7, 2022
Cost-Effectiveness and Budget Impact of Comprehensive Anemia Management, The First Pillar of Patient Blood Management, on the Turkish Healthcare SystemMehtap Tatar, Neslihan Alkış, Çiğdem Yıldırım Güçlü, et al.
Pageof 102